Onderneming Knight Therapeutics Inc. Deutsche Boerse AG
Aandelen
04K
CA4990531069
Farmaceutische producten
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,88 EUR | +1,04% |
|
+3,78% | +9,09% |
Vakgebied
Aantal werknemers: 725
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products, Consumer Health Products and Medical Devices
100,0
%
| 294 | 100,0 % | 328 | 100,0 % | +11,80% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Brazil
51,3
%
| 135 | 45,9 % | 168 | 51,3 % | +24,86% |
Rest of Latin America
16,8
%
| 40 | 13,7 % | 55 | 16,8 % | +37,17% |
Colombia
13,6
%
| 46 | 15,7 % | 45 | 13,6 % | -3,24% |
Argentina
7,3
%
| 48 | 16,4 % | 24 | 7,3 % | -49,95% |
Canada
6,0
%
| 11 | 3,9 % | 20 | 6,0 % | +73,39% |
Other
5,0
%
| 13 | 4,4 % | 16 | 5,0 % | +26,27% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01-11-13 |
Jonathan Goodman
FOU | Founder | 56 | 01-11-13 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 20-06-16 |
Leopoldo Bosano
COO | Chief Operating Officer | - | - |
Monica Percario
CTO | Chief Tech/Sci/R&D Officer | - | - |
Susan Emblem
HRO | Human Resources Officer | - | 01-10-20 |
Amal Khouri
PRN | Corporate Officer/Principal | - | 01-08-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 06-01-14 |
Jonathan Goodman
FOU | Founder | 56 | 01-11-13 |
Robert Lande
BRD | Director/Board Member | 61 | 01-01-13 |
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01-11-13 |
Nicolás Spiguel
BRD | Director/Board Member | 48 | 01-01-20 |
Michael Tremblay
BRD | Director/Board Member | 71 | 01-01-19 |
Janice Murray
BRD | Director/Board Member | 58 | 01-01-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 101 283 482 | 55 223 453 ( 54,52 %) | 0 | 54,52 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 153 897 | 9.50% | 336 938 $ |
Bedrijfsgegevens
Knight Therapeutics, Inc.
3400 de Maisonneuve West Suite 1055
H3Z 3B8, Montréal
+514-484-4483
http://www.gud-knight.com![Adres Knight Therapeutics Inc.(04K)](https://cdn.zonebourse.com/static/address/16421263.png)
Sector
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,09% | 70,89 mld. | |
+16,90% | 9,08 mld. | |
+11,92% | 4,53 mld. | |
-21,91% | 4,47 mld. | |
+22,70% | 3,97 mld. | |
+2,19% | 2,08 mld. | |
+11,95% | 2,04 mld. | |
-36,00% | 1,94 mld. | |
-45,17% | 1,77 mld. |